Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-18

Clinical Trial Update: HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating HSV-2 suppression to reduce maternal HIV-1 RNA levels during pregnancy and breastfeeding.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Washington | Conditions: HIV Infections, Herpes Simplex | Phase 2 | Status: COMPLETED | Results posted: 2012-04-18